Abstract
It is well recognised that the Major Histocompatibility Complex (MHC) harbours the main psoriasis susceptibility locus (PSORS1, Psoriasis Susceptibility 1). Nonetheless, linkage analyses have repeatedly shown that the PSORS1 locus account for less than 50% of the disease family clustering. On this basis, it is widely agreed that additional loci must contribute to psoriasis susceptibility, either by interacting directly with or by modifying the effect of the PSORS1 gene(s). To date, at least eight putative disease susceptibility regions have been mapped outside of the MHC (PSORS2-9). However, the search for the underlying genetic determinants has been seriously hindered by the difficulty of replicating linkage to these loci. The small disease-risk conferred by non-MHC genes and the likely occurrence of genetic heterogeneity are regarded as the main factors affecting the power of linkage studies and confounding the interpretation of experimental results. Evidence supporting some non-MHC loci has been provided by their close overlap with genomic regions conferring susceptibility to other inflammatory disorders. These observations indicate that clinically distinct autoimmune diseases might share common pathogenic pathways, suggesting that future advances in the understanding of single disorders could benefit the wider research community studying common inflammatory diseases.
Keywords: psoriasis susceptibility, non-mhc loci
Current Genomics
Title: The Long and Winding Road: Searching for Non-MHC Psoriasis Susceptibility Loci
Volume: 6 Issue: 1
Author(s): Francesca Capon and Emiliano Giardina
Affiliation:
Keywords: psoriasis susceptibility, non-mhc loci
Abstract: It is well recognised that the Major Histocompatibility Complex (MHC) harbours the main psoriasis susceptibility locus (PSORS1, Psoriasis Susceptibility 1). Nonetheless, linkage analyses have repeatedly shown that the PSORS1 locus account for less than 50% of the disease family clustering. On this basis, it is widely agreed that additional loci must contribute to psoriasis susceptibility, either by interacting directly with or by modifying the effect of the PSORS1 gene(s). To date, at least eight putative disease susceptibility regions have been mapped outside of the MHC (PSORS2-9). However, the search for the underlying genetic determinants has been seriously hindered by the difficulty of replicating linkage to these loci. The small disease-risk conferred by non-MHC genes and the likely occurrence of genetic heterogeneity are regarded as the main factors affecting the power of linkage studies and confounding the interpretation of experimental results. Evidence supporting some non-MHC loci has been provided by their close overlap with genomic regions conferring susceptibility to other inflammatory disorders. These observations indicate that clinically distinct autoimmune diseases might share common pathogenic pathways, suggesting that future advances in the understanding of single disorders could benefit the wider research community studying common inflammatory diseases.
Export Options
About this article
Cite this article as:
Capon Francesca and Giardina Emiliano, The Long and Winding Road: Searching for Non-MHC Psoriasis Susceptibility Loci, Current Genomics 2005; 6 (1) . https://dx.doi.org/10.2174/1389202053202102
DOI https://dx.doi.org/10.2174/1389202053202102 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Applications of Autoimmunity to Citrullinated Proteins in Rheumatoid Arthritis, from Improving Diagnostics to Future Therapies
Recent Patents on Inflammation & Allergy Drug Discovery Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy Role of Positron Emission Tomography for Central Nervous System Involvement in Systemic Autoimmune Diseases: Status and Perspectives
Current Medicinal Chemistry B Cells and Beyond: Therapeutic Opportunities Targeting Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Autoantibody-Induced Formation of Immune Complexes in Normal Human Serum
Current Pharmaceutical Design Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
Current Pharmaceutical Design Pathogenesis of Graves Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Trials for FTY720 (Fingolimod): A New Generation of Immunomodulators Structurally Similar to Sphingosine
Reviews on Recent Clinical Trials Directing an Appropriate Immune Response: The Role of Defense Collagens and other Soluble Pattern Recognition Molecules
Current Drug Targets Targeting Cytokines of the Interleukin-12 Family in Autoimmunity
Current Medicinal Chemistry Immunotherapy-Based Strategies for the Treatment of Autoimmune Diabetes: Searching for the Cure
Current Pharmaceutical Design Neuromyelitis Optica (NMO IgG+) and Genetic Susceptibility, Potential Ethnic Influences
Central Nervous System Agents in Medicinal Chemistry Hot topic: Editorial [Therapeutic Potential of Peptide Motifs - Part IV] (Jean Claude Herve)
Current Pharmaceutical Design Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Current Clinical Pharmacology Immunology of VIP: A Review and Therapeutical Perspectives
Current Pharmaceutical Design Potential Role of TRAIL in the Management of Autoimmune Diabetes Mellitus
Current Pharmaceutical Design Target Therapies in Systemic Lupus Erythematosus: Current State of the Art
Mini-Reviews in Medicinal Chemistry The Expanding Role of TNF-Receptor Super Family Member CD40 (tnfrsf5) in Autoimmune Disease: Focus on Th40 Cells
Current Immunology Reviews (Discontinued) Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Current Pharmaceutical Design Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design